NEUNEUREN PHARMACEUTICALS LIMITEDMarket sensitive

Q1 2026 DAYBUE net sales US$101m, up 20% from Q1 2025

Date and time
Announcement type
Company Update

More from Health Care

More News

ARLCompany Update12 November 2026

Ardea Resources (ASX: ARL) Scandium Study Models US$510m NPV